Search IPOs
GKSL · NSE,BSE · Healthcare
Gujarat Kidney IPO listed on 30 Dec 2025 on NSE,BSE at ₹120.00, a gain of 5.26% over the issue price of ₹114.00. The IPO was subscribed 3.92x overall.
Gujarat Kidney IPO tentative timeline covering IPO opening, closing, basis of allotment, refunds, demat credit, and listing dates.
| Event | Date |
|---|---|
| IPO Open Date | 22 Dec 2025 |
| IPO Close Date | 24 Dec 2025 |
| Basis of Allotment | 26 Dec 2025 |
| Initiation of Refunds | 29 Dec 2025 |
| Credit of Shares to Demat | 29 Dec 2025 |
| Listing Date | 30 Dec 2025 |
Listing day gain
+5.26%
Listed at ₹120 (issue ₹114)
Issue
₹114
Listing
₹120
Current
₹104.54
-8.3% vs issue
Day range
₹102.9 – ₹123
Issue Size
22,000,000 shares
(aggregating up to ₹250.80 Cr)
Issue Price
₹108 – ₹114
Face Value
₹2/share
Market Lot
128 shares
Retail Min Investment
₹14,592
Listing At
NSE,BSE
Sale Type
fresh issue
Fresh Issue
[.]
Offer for Sale
[.]
Issue Type
book building
Open Date
22 Dec
Close Date
24 Dec
Allotment
26 Dec
Listing
30 Dec
Last updated: 9 months ago
| Date | IPO Issue Price (₹) | GMP (₹) | Est. Listing Price (₹) | Est. Profit Amount (₹) | Est. Profit % | Last Updated |
|---|---|---|---|---|---|---|
| 30 Dec 2025 Latest | ₹114 | ₹1.5 | ₹115.5 | ₹1.5 |
1.32%
|
12:00 PM |
| 29 Dec 2025 | ₹114 | ₹1.5 | ₹115.5 | ₹1.5 |
1.32%
|
12:00 PM |
Showing the 2 most recent GMP entries.
View full GMP historyLatest snapshot: 04 Jan 2026
| Category | Subscribed (x) |
|---|---|
| QIB | 0.89x |
| NII | 4.14x |
| bNII (bids above ₹10L) | 3.77x |
| sNII (bids below ₹10L) | 4.88x |
| Retail Investors | 14.22x |
| Total | 3.92x |
Showing the latest subscription snapshot.
View full subscription historyDr. Pragnesh Yashwantsinh Bharpoda, Dr. Bhartiben Pragnesh Bharpoda, Dr. Yashwantsingh Motisinh Bharpoda and Anitaben Yashwantsinh Bharpoda are the company promoters.
New to lot sizes and investment limits? Read our guide on IPO lot size and minimum investment.
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 128 | ₹14,592 |
| Retail (Max) | 13 | 1,664 | ₹189,696 |
| S-HNI (Min) | 14 | 1,792 | ₹204,288 |
| S-HNI (Max) | 68 | 8,704 | ₹992,256 |
| B-HNI (Min) | 69 | 8,832 | ₹1,006,848 |
Want to understand how IPO shares are divided between investor categories? Read our guide on IPO reservation structure.
| Category | Shares Offered |
|---|---|
| QIB Shares Offered | 16,500,000 (75.00%) |
|
•
Anchor Investor Shares Offered
|
8,773,120 (39.88%) |
|
•
QIB (Ex. Anchor) Shares Offered
|
7,726,880 (35.12%) |
| NII (HNI) Shares Offered | 3,300,000 (15.00%) |
|
•
bNII > ₹10L
|
2,200,000 (10.00%) |
|
•
sNII < ₹10L
|
1,100,000 (5.00%) |
| Retail Shares Offered | 2,200,000 (10.00%) |
| Total Shares Offered | 22,000,000 (100.00%) |
Incorporated in December 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) is a regional multispeciality healthcare provider focused on secondary and tertiary care in central Gujarat. It operates 6 hospitals and 3 in-house pharmacies across Vadodara, Godhra, Bharuch, Borsad, and Anand, with a total bed capacity of 400 (operational: 250). Services span general medicine, surgery, orthopaedics, urology, cardiology, nephrology, neurology, and more, supported by in-house diagnostics.
Growth: Revenue surged from ₹0.79 Cr in FY22 to ₹4.77 Cr in FY24 and ₹18.67 Cr in H1 FY25, driven by strategic acquisitions (e.g., Raj Palmland Hospital) and expansion plans using IPO proceeds for new facilities and equipment.
Key Strengths: Strong regional presence in underserved markets, high operational efficiency (EBITDA margin ~41-50%), experienced team (322 employees, including 53 consultants and 138 nurses), low debt (D/E ratio 0.18), and focus on affordable, quality care.
Standalone · ₹ in Crores
| Particulars | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| Total Revenue | 0 | 5.48 | 40.4 |
| Profit After Tax (PAT) | -0.01 | 1.71 | 9.5 |
| EBITDA | -0.01 | 1.95 | 16.55 |
| Total Assets | 3.87 | 20.53 | 55.34 |
| Net Worth | 0.37 | 10.8 | 25.71 |
| Reserves & Surplus | 0.17 | 10.6 | 14.57 |
| Total Borrowing | - | 1.94 | 3.88 |
Revenue & Profit Trend
The basis of allotment for Gujarat Kidney IPO was finalised on 26 Dec 2025. You can check your allotment status using your PAN number or application number on the MUFG Intime India Pvt.Ltd portal or BSE.
The Gujarat Kidney IPO is expected to open in Dec 2025, subject to SEBI approval. Final dates will be updated once announced officially.
The price band for Gujarat Kidney IPO is ₹108.00 - ₹114.00 per share.
As per market sources, Gujarat Kidney IPO GMP is currently ₹1.50. GMP is tracked daily in the grey market. GMP indicates unofficial demand but does not guarantee listing gains.
The subscription status for Gujarat Kidney IPO stands at 3.92x overall.
The listing date for Gujarat Kidney IPO is 30 Dec 2025.
No comments yet. Be the first to comment!
